| Profiling B cell immunodominance after SARS-CoV-2 infection reveals antibody evolution to non-neutralizing viral targets HL Dugan, CT Stamper, L Li, S Changrob, NW Asby, PJ Halfmann, ... Immunity 54 (6), 1290-1303. e7, 2021 | 138* | 2021 |
| SARS-CoV-2 infection severity is linked to superior humoral immunity against the spike JJ Guthmiller, O Stovicek, J Wang, S Changrob, L Li, P Halfmann, ... MBio 12 (1), 10.1128/mbio. 02940-20, 2021 | 103 | 2021 |
| Preexisting immunity shapes distinct antibody landscapes after influenza virus infection and vaccination in humans HL Dugan, JJ Guthmiller, P Arevalo, M Huang, YQ Chen, KE Neu, ... Science translational medicine 12 (573), eabd3601, 2020 | 97 | 2020 |
| Broadly neutralizing antibodies target a haemagglutinin anchor epitope JJ Guthmiller, J Han, HA Utset, L Li, LYL Lan, C Henry, CT Stamper, ... Nature 602 (7896), 314-320, 2022 | 89 | 2022 |
| Imprinting, immunodominance, and other impediments to generating broad influenza immunity M Knight, S Changrob, L Li, PC Wilson Immunological reviews 296 (1), 191-204, 2020 | 46 | 2020 |
| First exposure to the pandemic H1N1 virus induced broadly neutralizing antibodies targeting hemagglutinin head epitopes JJ Guthmiller, J Han, L Li, AW Freyn, STH Liu, O Stovicek, CT Stamper, ... Science translational medicine 13 (596), eabg4535, 2021 | 45 | 2021 |
| Severe COVID-19 induces autoantibodies against angiotensin II that correlate with blood pressure dysregulation and disease severity PS Briquez, SJ Rouhani, J Yu, AR Pyzer, J Trujillo, HL Dugan, ... Science Advances 8 (40), eabn3777, 2022 | 35 | 2022 |
| Cross-neutralization of emerging SARS-CoV-2 variants of concern by antibodies targeting distinct epitopes on spike S Changrob, Y Fu, JJ Guthmiller, PJ Halfmann, L Li, CT Stamper, ... Mbio 12 (6), e02975-21, 2021 | 32 | 2021 |
| Persistence of Long-lived Memory B Cells specific to Duffy Binding Protein in individuals exposed to Plasmodium vivax S Changrob, AM McHenry, MH Nyunt, J Sattabongkot, ET Han, JH Adams, ... Scientific Reports 8 (1), 8347, 2018 | 25 | 2018 |
| Naturally acquired humoral and cellular immune responses to Plasmodium vivax merozoite surface protein 8 in patients with P. vivax infection Y Cheng, B Wang, S Changrob, JH Han, J Sattabongkot, KS Ha, ... Malaria journal 16, 1-12, 2017 | 21 | 2017 |
| Immunogenicity of the Plasmodium vivax merozoite surface protein 1 paralog in the induction of naturally acquired antibody and memory B cell responses HMK Min, S Changrob, PT Soe, JH Han, F Muh, SK Lee, P Chootong, ... Malaria journal 16, 1-12, 2017 | 19 | 2017 |
| Immunogenicity of glycosylphosphatidylinositol-anchored micronemal antigen in natural Plasmodium vivax exposure S Changrob, JH Han, KS Ha, WS Park, SH Hong, P Chootong, ET Han Malaria journal 16, 1-11, 2017 | 18 | 2017 |
| Naturally-acquired cellular immune response against Plasmodium vivax merozoite surface protein-1 paralog antigen S Changrob, C Leepiyasakulchai, T Tsuboi, Y Cheng, CS Lim, ... Malaria journal 14, 1-9, 2015 | 15 | 2015 |
| Naturally-Acquired Immune Response against Plasmodium vivax Rhoptry-Associated Membrane Antigen S Changrob, B Wang, JH Han, SK Lee, MH Nyunt, CS Lim, T Tsuboi, ... PLoS One 11 (2), e0148723, 2016 | 14* | 2016 |
| Interferon-γ signal drives differentiation of T-bethi atypical memory B cells into plasma cells following Plasmodium vivax infection P Kochayoo, P Thawornpan, K Wangriatisak, S Changrob, ... Scientific Reports 12 (1), 4842, 2022 | 13 | 2022 |
| Improved integration of single-cell transcriptome and surface protein expression by LinQ-View L Li, HL Dugan, CT Stamper, LYL Lan, NW Asby, M Knight, O Stovicek, ... Cell Reports Methods 1 (4), 2021 | 13 | 2021 |
| The acquisition of long-lived memory B cell responses to merozoite surface protein-8 in individuals with Plasmodium vivax infection P Kochayoo, N Kittisenachai, S Changrob, K Wangriatisak, F Muh, ... Malaria Journal 18, 1-10, 2019 | 12 | 2019 |
| Site of vulnerability on SARS-CoV-2 spike induces broadly protective antibody against antigenically distinct Omicron subvariants S Changrob, PJ Halfmann, H Liu, JL Torres, JJC McGrath, G Ozorowski, ... The Journal of Clinical Investigation 133 (8), 2023 | 6 | 2023 |
| Variable immunogenicity of a vivax malaria blood-stage vaccine candidate SL De, S May, K Shah, M Slawinski, S Changrob, S Xu, SJ Barnes, ... Vaccine 39 (19), 2668-2675, 2021 | 6 | 2021 |
| The persistence of naturally acquired antibodies and memory B cells specific to rhoptry proteins of Plasmodium vivax in patients from areas of low malaria … P Kochayoo, S Changrob, K Wangriatisak, SK Lee, P Chootong, ET Han Malaria journal 18, 1-13, 2019 | 5 | 2019 |
